Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolaus Sarafoff

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Current Pharmaceutical Design|June 26, 2012
Clinical use of clopidogrelNikolaus Sarafoff, Robert A Byrne, Dirk Sibbing
Drug Safety|August 13, 2009
Drug-eluting stents in percutaneous coronary intervention: a benefit-risk assessmentRobert A Byrne, Nikolaus Sarafoff, Adnan Kastrati, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 7, 2004
Autocatalytic self-propagation of misfolded prion proteinJan Bieschke, Petra Weber, Nikolaus Sarafoff, et al.
Journal of the American College of Cardiology|March 26, 2013
Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulationNikolaus Sarafoff, Amadea Martischnig, Jill Wealer, et al.
Journal of Electrocardiology|January 23, 2013
Association of ST-elevation and non-ST-elevation presentation on ECG with transmurality and size of myocardial infarction as assessed by contrast-enhanced magnetic resonance imagingNikolaus Sarafoff, Tibor Schuster, Ruth Vochem, et al.
American Heart Journal|March 12, 2011
Lack of impact of calcium-channel blockers on the pharmacodynamic effect and the clinical efficacy of clopidogrel after drug-eluting stentingNikolaus Sarafoff, Lydia Neumann, Tanja Morath, et al.
Journal of Atherosclerosis and Thrombosis|July 12, 2021
Meta-Analysis of Short vs. Prolonged Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation and Role of Continuation with either Aspirin or a P2Y<sub>12</sub> Inhibitor ThereafterShqipdona Lahu, Peter Bristot, Senta Gewalt, et al.
Thrombosis and Haemostasis|July 29, 2010
Risk of drug-eluting stent thrombosis in patients receiving proton pump inhibitorsNikolaus Sarafoff, Dirk Sibbing, Ulrich Sonntag, et al.
Plos One|July 25, 2015
ICD Shock, Not Ventricular Fibrillation, Causes Elevation of High Sensitive Troponin T after Defibrillation Threshold Testing--The Prospective, Randomized, Multicentre TropShock-TrialVerena Semmler, Jürgen Biermann, Bernhard Haller, et al.
European Heart Journal|February 18, 2010
Oral anticoagulation with coumarin derivatives and antiplatelet effects of clopidogrelDirk Sibbing, Nicolas von Beckerath, Tanja Morath, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Current Pharmaceutical Design|June 26, 2012
Clinical use of clopidogrelNikolaus Sarafoff, Robert A Byrne, Dirk Sibbing
Drug Safety|August 13, 2009
Drug-eluting stents in percutaneous coronary intervention: a benefit-risk assessmentRobert A Byrne, Nikolaus Sarafoff, Adnan Kastrati, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 7, 2004
Autocatalytic self-propagation of misfolded prion proteinJan Bieschke, Petra Weber, Nikolaus Sarafoff, et al.
Journal of the American College of Cardiology|March 26, 2013
Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulationNikolaus Sarafoff, Amadea Martischnig, Jill Wealer, et al.
Journal of Electrocardiology|January 23, 2013
Association of ST-elevation and non-ST-elevation presentation on ECG with transmurality and size of myocardial infarction as assessed by contrast-enhanced magnetic resonance imagingNikolaus Sarafoff, Tibor Schuster, Ruth Vochem, et al.
American Heart Journal|March 12, 2011
Lack of impact of calcium-channel blockers on the pharmacodynamic effect and the clinical efficacy of clopidogrel after drug-eluting stentingNikolaus Sarafoff, Lydia Neumann, Tanja Morath, et al.
Journal of Atherosclerosis and Thrombosis|July 12, 2021
Meta-Analysis of Short vs. Prolonged Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation and Role of Continuation with either Aspirin or a P2Y<sub>12</sub> Inhibitor ThereafterShqipdona Lahu, Peter Bristot, Senta Gewalt, et al.
Thrombosis and Haemostasis|July 29, 2010
Risk of drug-eluting stent thrombosis in patients receiving proton pump inhibitorsNikolaus Sarafoff, Dirk Sibbing, Ulrich Sonntag, et al.
Plos One|July 25, 2015
ICD Shock, Not Ventricular Fibrillation, Causes Elevation of High Sensitive Troponin T after Defibrillation Threshold Testing--The Prospective, Randomized, Multicentre TropShock-TrialVerena Semmler, Jürgen Biermann, Bernhard Haller, et al.
European Heart Journal|February 18, 2010
Oral anticoagulation with coumarin derivatives and antiplatelet effects of clopidogrelDirk Sibbing, Nicolas von Beckerath, Tanja Morath, et al.
Pageof 3